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Objectives. In public health and clinical settings insufficient dissemination of evidence-based practices limits the reach of new
discoveries to broad populations. This study aimed to describe characteristics of the dissemination process by researchers across
three countries (Brazil, United Kingdom, and United States), explore how designing for dissemination practices has been used,
and analyze factors associated with dissemination.Methods. A similar online survey was used to query researchers across the three
countries; data were pooled to draw cross-country conclusions. Findings. This study identified similarities and differences between
countries. Importance of dissemination to nonresearcher audiences was widely recognized as important; however, traditional
academic venues were the main dissemination method. Several factors were associated with self-rated dissemination effort in the
pooled sample, but these predictive factors (e.g., support and resources for dissemination) had low prevalence. Less than one-third
of researchers rated their level of effort for dissemination as excellent. Respondents reported limited support and resources to
make it easier for researchers who might want to disseminate their findings. Conclusion. Though intentions show the importance
of dissemination, researchers across countries lack supports to increase dissemination efforts. Additional resources and training in
designing for dissemination along with improved partnerships could help bridge the research-practice gap.
1. Introduction
Though the United States (US), the United Kingdom (UK),
and Brazil differ in many ways, across all three, there is sig-
nificant spending on research to prevent and treat important
health issues, such as cardiovascular disease [1–4]. While
evidence is being produced, the pipeline tomove this research
into practice is far too long. It has been widely cited that
it takes 17 years for research to make it into practice and
that along the way most discoveries are lost, leaving only
14% of the evidence discovered to benefit health [5]. In both
public health and clinical settings, there remains insufficient
dissemination of evidence-based practices, resulting in new
discoveries not reaching broad populations and populations
most in need [6–8].This is particularly true for cardiovascular
disease prevention and treatment, for which many evidence-
based strategies are available but have not had maximum
population impact [9]. Dissemination has been defined as “an
active approach of spreading evidence-based interventions to
the target audience via determined channels using planned
strategies” [10].
There is a need to speed up the pipeline from discovery
to application (e.g., discovery of a new smoking cessation
technique to widespread use across clinical and public health
settings) [7]. Potential solutions to bring research to practice
include involving stakeholders [11–16] in the research process
(e.g., design, data gathering, and analysis) and/or evaluation
process (also referred to as practice-based research [17]) and
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using theories and frameworks to guide dissemination efforts
[18, 19]. Designing for dissemination (D4D) has been recom-
mended as a strategy to help bridge the research-practice gap
[20]. Researchers are encouraged to involve dissemination
partners early on in the research process. Encouraging a
role for potential adopters in research discovery creates a
more collaborative approach [21–25]. Involving this future
target audience in early, developmental phases of the research
process, rather than at the end of a study [22, 26], can
help researchers better incorporate issues related to external
validity and translation for use in practice settings into
intervention development [27–29].
The objectives of the current study are threefold. (1)
Describe characteristics of the dissemination process by
researchers across three countries; (2) explore how D4D
practices have been used; (3) analyze factors associated with
dissemination.
2. Methods
2.1. Sampling. Methods for sampling for each country have
been presented in detail elsewhere [25, 30]. Briefly, in the
US, sampling was conducted using the 12 journals with the
highest impact factors in the category “public, environmental,
and occupational health” using the lead author’s affiliation,
the NIH RePORTER database (an electronic tool for search-
ing NIH-funded research projects), and researchers affiliated
with the Prevention Research Centers (PRCs) Program of
the Center for Disease Control and Prevention (CDC) from
each PRCs website. These sources resulted in an initial pool
of 488 valid investigators. Researchers were surveyed in
2012. In the UK, investigators from eight funding agencies
conducting applied health services and public health research
were identified. From these sources, the sample included
536 potential participants. Surveys took place in 2008. In
Brazil a sample of 536 potential participants (all researchers
classified as part of one of the health sciences areas as
defined by Brazilian research agencies) was drawn from the
database available at the Brazilian Council for Scientific and
Technological Development or CNPq (Conselho Nacional
de Desenvolvimento Cient´ıfico e Tecnolo´gico). Participants
were surveyed from October to November 2012.
2.2. Questionnaire Development and Administration. Devel-
opment of the UK survey [30] was informed by a systematic
review of dissemination planning frameworks and strategies
[18], which suggested key elements influencing the effec-
tiveness of dissemination: planning activities, targeting audi-
ences, selecting communication channels, and evaluating
impact.Thus, the questionnaire had several parts.These were
designed to elicit general researcher views and attitudes on
the dissemination of research, think about a particular grant
and capture any research impacts on health policy, clinical
guideline development, or the organization and/or delivery
of healthcare and services [31, 32], and obtain self-reported
descriptions of research impacts (using four open-ended
questions). This survey included 36 open and closed ques-
tions and took approximately 30 minutes to complete. Addi-
tional details about the UK survey can be found elsewhere
[30]. This survey served as the basis for the surveys in the
US and Brazil. The US and Brazil surveys included 35 items
and 51 items and took respondents a median of 11 minutes
and 15 minutes to complete, respectively. Only closed-ended
items that were present on all three surveys were included
in the current analysis. All surveys were conducted online;
participants provided informed consent, and institutional
review board approval was obtained from each of the three
universities involved; additional details about the surveys and
their administration can be found elsewhere [25, 30]. So that
pooled analyses and those comparing across countries could
be conducted, only survey items common across all three
countries were included in the current analysis.
2.3. Data Analysis. Data were analyzed in SPSS version 20
(SPSS Inc, Chicago, IL). Distributions for each variable were
explored across countries, and differences were explored
using chi-squared tests. Associations between several pre-
dictor variables and self-rated effort to disseminate research
findings to nonresearch audiences (i.e., “overall, how do you
rate your efforts to disseminate your research findings to
nonresearch audiences?” with response options as follows:
excellent, good, adequate, poor, and not sure) were explored.
The predictor variables included reasons why the researchers
disseminate (including to influence policy/practice or to
satisfy grant/contractual obligations), importance of dissemi-
nation, access to resources/structures (including a formal dis-
semination strategy or dedicated person for dissemination),
adherence to designing for dissemination practices such as
the stage at which dissemination-related activities occur, and
dissemination processes and actions such as the frequency
of producing research summaries. These predictors were
selected as those hypothesized by the research team as
most likely to be related to the outcome, and the set was
limited to these variables to minimize the potential for extra
comparisons and the likelihood of type 1 error. Multivariable
logistic regression was used to determine odds ratios for
excellent/good compared to poor self-rated dissemination
effort for each country and in the pooled sample (with and
without adjustment for country).The extreme categorieswere
created to maximize differences between groups.
3. Results
Across countries, the samples included similar number of
researcherswith 277 respondents in Brazil, 232 in theUK, and
266 in the US. Response rates were 42% in Brazil and around
half for the UK (50%) and the US (54%).
3.1. Reasons to Disseminate. Across countries, researchers
cited similar reasons to disseminate their findings (Table 1).
For the pooled data, roughly eight out of ten respondents
considered “to raise awareness of the findings,” “to influence
policy or practice,” and “to influence practice” as themain rea-
sons to disseminate their findings. Some differences existed
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Table 1: Reasons, resources, and methods used to disseminate the results of research in public health in Brazil, US, and UK %a (𝑛).
Dissemination characteristics Brazil United Kingdom United States Total 𝑃 value (𝜒2)
Reasons to disseminateb
Raise awareness of the findings 92.1 (209) 93.1 (216) 94.4 (251) 93.2 (676) .598
Influence practice or policy 91.2 (207) 93.1 (216) 90.2 (240) 91.4 (663) .512
Influence practice 81.1 (184) 83.6 (194) 80.1 (213) 81.5 (591) .583
Influence policy 78.0 (177) 85.3 (198) 75.6 (201) 79.4 (576) .021
Stimulate discussion or debate 86.3 (196) 74.6 (173) 70.7 (188) 76.8 (557) <.01
Attract future funding 52.4 (119) 62.5 (145) 52.3 (139) 55.6 (403) .037
Raise the organizational profile 52.4 (119) 64.7 (150) 42.1 (112) 52.6 (381) <.01
Promote public understanding of science 47.1 (107) 40.1 (93) 57.9 (154) 48.8 (354) <.01
Justify public funding 60.4 (137) 48.3 (112) 39.1 (104) 48.7 (353) <.01
Satisfy grant/contractual obligations 15.0 (34) 36.6 (85) 41.4 (110) 31.6 (229) <.01
Improve your own communication 29.1 (66) 24.1 (56) 21.1 (56) 24.6 (178) .117
Importance of dissemination to nonresearch audiences
Importance to your own work
Very important 77.7 (171) 69.6 (160) 54.2 (143) 66.4 (474)
Important 19.5 (43) 24.3 (56) 24.2 (64) 22.8 (163)
Somewhat/not important/NS 2.7 (6) 6.1 (14) 21.6 (57) 10.8 (77) <.01
Importance to the work of your unit/department
Very important 75.9 (167) 65.7 (151) 37.7 (100) 58.5 (418)
Important 22.7 (50) 26.5 (61) 24.5 (65) 24.6 (176)
Somewhat/not important/IDKc 1.4 (3) 7.8 (18) 37.7 (100) 16.9 (121) <.01
Resources & structures for dissemination in unit/department
Formal communication/dissemination strategy or
plan 27.8 (62) 20.2 (46) 31.8 (84) 26.9 (192) .014
Dedicated person or team responsible for
dissemination-related activities 32.0 (71) 20.6 (47) 52.6 (140) 36.0 (258) <.01
Method of disseminationb
Academic journals 98.7 (224) 97.8 (227) 100.0 (266) 98.9 (717) .067
Academic conferences 91.6 (208) 96.1 (223) 92.5 (246) 93.4 (677) .117
Report to funders 79.7 (181) 91.4 (212) 68.0 (181) 79.2 (574) <.01
Seminars and/or workshops 69.2 (157) 71.1 (165) 60.9 (162) 66.8 (484) .035
Press releases 32.6 (74) 48.3 (112) 62.0 (165) 48.4 (351) <.01
Face to face meetings 49.8 (113) 40.1 (93) 53.4 (142) 48.0 (348) .01
Other conferences 21.6 (49) 55.2 (128) 42.5 (113) 40.0 (290) <.01
Media interviews 32.6 (74) 31.9 (74) 50.8 (135) 39.0 (283) <.01
Newsletters 13.7 (31) 39.2 (91) 45.1 (120) 33.4 (242) <.01
Email alerts 6.2 (14) 7.8 (18) 22.2 (59) 12.6 (91) <.01
Targeted mailings 3.1 (7) 16.4 (38) 16.2 (43) 12.1 (88) <.01
Designing for dissemination/processes/actions
Stage in the research process that
dissemination-related activities are planned
Early 60.0 (132) 35.2 (80) 45.1 (120) 46.6 (332)
Late 36.8 (81) 64.8 (147) 39.1 (104) 46.6 (332)
Never 3.2 (7) 0.0 (0) 15.8 (42) 6.9 (49) <.01
Frequency that research summaries/key messages
are written for specific nonresearch audiences
Always/usually 34.7 (76) 31.3 (71) 32.0 (85) 32.6 (232)
Sometimes 22.8 (50) 48.5 (110) 37.6 (100) 36.5 (260)
Rarely/never/NS 42.5 (93) 20.3 (46) 30.5 (81) 30.9 (220) <.01
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Table 1: Continued.
Dissemination characteristics Brazil United Kingdom United States Total 𝑃 value (𝜒2)
Frequency the impact of your research is evaluated?
Always/usually 22.4 (49) 13.3 (30) 15.5 (41) 16.9 (120)
Sometimes/rarely 55.7 (122) 69.5 (157) 56.8 (150) 60.5 (429)
Never 19.2 (42) 17.3 (39) 26.5 (70) 21.3 (151)
Not sure 2.7 (6) 0.0 (0) 1.1 (3) 1.3 (9) <.01
Frequency that a framework/theory is used to plan
dissemination-related activities
Always/usually 10.8 (24) 8.8 (20) 16.7 (44) 12.3 (88)
Sometimes/rarely 22.4 (50) 48.5 (110) 38.4 (101) 36.6 (261)
Never 60.1 (134) 39.6 (90) 25.9 (68) 41.0 (292)
Not sure 6.7 (15) 3.1 (7) 8.7 (23) 6.3 (45)
Do not plan dissemination activities 0.0 (0) 0.0 (0) 10.3 (27) 3.8 (27) <.01
Time dedicated to dissemination-related activities to
nonresearch audiences.
<5% 36.5 (80) 31.4 (71) 54.4 (143) 41.5 (294)
5–20% 35.6 (78) 52.7 (119) 34.6 (91) 40.7 (288)
>20% 27.9 (61) 15.9 (36) 11.0 (29) 17.8 (126) <.01
a% within local; bthose responding “yes”; cIDK = I do not know.
between countries. Stimulating discussion or debate (86%)
and justifying public funding (60%) were reported most
frequently by Brazilian researchers compared to researchers
in the other countries, while satisfying grant/contractual obli-
gations (15%)was lower among these researchers. UK respon-
dents ranked influencing policy, attracting future funding
(62%), and raising the organizational profile (65%) as higher
than the other two countries, while they reported promoting
public understanding of science (40%) as lower. Compared
to researchers in the other countries, US researchers selected
promoting public understanding of science (58%) and to
satisfy grant/contractual obligations (41%) frequently. How-
ever, US researchers selected the reasons of justifying public
funding (39%) and raising the organizational profile (42%)
less often than researchers in other countries.
3.2. Importance. In the pooled sample, almost two-thirds
of respondents reported that dissemination to nonresearch
audiences was very important to their own research and
roughly half of the participants reported that dissemina-
tion was very important for their unit/department. The
importance of dissemination differed by country (Table 1).
Seventy-eight percent of Brazilian researchers and 70% of
UK researchers reported that dissemination of their own
research was very important, but this was the case for 54%
of US researchers.Though the number reporting importance
of dissemination of their unit/department’s work was slightly
lower overall (59% versus 66% for their own work), the
pattern by country remained, with 76% of Brazilian and 66%
ofUK, but only 38%ofUS, researchers reporting thiswas very
important.
3.3. Resources/Structures. Access to a formal dissemination
strategy (27%) and a dedicated person or team (36%) was
low in the pooled sample (Table 1). However, compared
to Brazil and UK researchers, US researchers reported the
highest access to resources (53%). In Brazil and UK roughly
a 30% and 20% reported access to a formal communication
strategy/plan or a dedicated person, respectively, while one-
third and one-half of US participants reported access to these
resources.
3.4. Dissemination Processes and Actions. Table 1 also
presents the methods researchers use for this dissemination
by country and for the total sample. Across countries, the
most frequently reported methods were academic journals
(99% overall) then academic conferences (81% overall).
Methods differed significantly by country. Brazil did not
rank any of the methods significantly more frequently than
any other countries but ranked press releases (33%), other
conferences (22%), newsletters (14%), and targeted mailings
(3%) less frequently. Researchers from the UK reported to
funders (91%) and other conferences (55%) more frequently
than other countries; they reported face-to-face meetings
(40%) less often. The only method US researchers reported
least frequently was seminars and/or workshops (61%). US
researchers reported several methods more frequently than
other countries; these included press releases (62%), media
interviews (51%), newsletters (45%), and email alerts (22%).
3.5. Designing for Dissemination. Table 1 reveals that, in the
overall sample, less than one-half of researchers reported
planning dissemination-related activities early and roughly
one-third reported they always or usually produce sum-
maries for nonresearch audiences. Additionally, several
important actions related to designing for dissemination
and other dissemination-related activities showed differ-
ences across countries (Table 1). Brazilian researches most
frequently reported planning dissemination-related activi-
ties early (60%, compared to 45% in the US and 35% in
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Table 2: Regression of predictor variables on self-rated disseminationa effort separately for each country and pooled (unadjusted and adjusted
for country) OR (95% CI).
Dissemination characteristics Brazil United Kingdom United States Pooled (crude) Pooled (adjb)
Reasons
Influence policy OR to influence practice 2.1 (0.5–8.3) 5.5 (0.9–35.0) 4.5 (1.2–16.5) 3.8 (1.7–8.7) 3.8 (1.7–8.8)
To satisfy grant/contractual obligations 0.5 (0.2–1.3) 1.1 (0.4–3.0) 0.9 (0.5–1.7) 0.7 (0.5–1.2) 0.8 (0.5–1.3)
Resources
Unit/department/school has formal
communication/dissemination strategy 3.0 (1.4–6.5) —
c 1.8 (0.9–3.6) 2.4 (1.5–3.9) 2.9 (1.8–4.7)
Dedicated person/team for dissemination
in unit/organization 1.7 (0.8–3.5) 2.6 (0.7–9.6) 1.3 (0.7–2.4) 1.2 (0.8–1.9) 1.6 (1.0–2.5)
Methods/actions
Frequency that research summaries/key
messages are written for specific
nonresearch audiences
5.9 (3.5–9.9) 4.8 (2.2–10.1) 21.9 (10.7–44.9) 8.5 (6.0–12.0) 8.2 (5.8–11.7)
Stage in the research process when
planning dissemination-related activities 3.2 (1.5–6.7) 3.2 (0.98–10.2) 3.9 (2.4–6.6) 2.8 (2.0–4.0) 3.3 (2.3–4.7)
aThe reference category is poor (versus excellent/good); badjusted for country w/dummy variables; ccould not be estimated due to small cell sizes.
the UK). However, Brazilian researches most frequently
reported rarely or never producing summaries for nonre-
search audiences (42% compared to 30% in the US and
20% in the UK). Though the frequency across all countries
was low (17%), 22% of Brazilian researchers reported that
they always or usually evaluate the impact of their research
on changing public health practice or policy; 26% of US
researches reported they never do this. Use of frameworks
was also quite low across all countries (12% reporting always
or usually), though it was the lowest in the UK (9%) and the
highest in the US (17%).
Overall, 18% of researchers reported spending greater
than 20% of their time on dissemination-related activities
(Table 1), with the highest in Brazil (28%) and the lowest in
the US (11%). Finally, roughly one-third of the participants
reported their own effort to disseminate their findings as
excellent or good, though the UK had the highest percentage
(33%) compared to Brazil (25%) and the US (28%) (Figure 1).
3.6. Factors Associated with Dissemination Efforts. Several
factors were associated with self-reported dissemination
effort, with important differences across countries (Table 2).
Researchers reporting that they disseminate their findings
to influence policy or practice were more likely to self-
rate themselves as putting more effort toward dissemination
(OR = 3.8; 95% CI = 1.7–8.8); this was not significant
for the UK or Brazil. Interestingly, there was no rela-
tionship between disseminating to satisfy grant/contractual
obligations and effort to disseminate; indicating inten-
tion to disseminate may not translate to behavior. Those
reporting a unit/department/school with formal commu-
nication/dissemination strategy had higher odds of better
self-rated effort in the pooled data (OR = 2.9; 95% CI =
1.8–4.7) as well as all individual countries except the US.
However, the positive association between reporting a dedi-
cated person/teamand self-reported effort to disseminatewas













Figure 1: Self-rated dissemination effort to disseminate public
health findings to nonresearch audiences in Brazil, US, and UK %
(IDK = I do not know).
(OR = 1.6; 95% CI = 1.0–2.5). In the pooled sample (OR =
8.2; 95% CI = 5.8–11.7) as well as all the individual countries,
reporting producing research summaries for nonresearch
audiences was also associated with higher self-rated effort to
disseminate. Finally, researchers who planned dissemination
at an earlier stage of their research process (pooled sample)
were more likely to report excellent/good dissemination
efforts (OR = 3.3; 95% CI = 2.3–4.7).
4. Discussion
This exploration of the characteristics of the dissemination
process by researchers across three countries found a number
of similarities as well as important differences between
countries. Researchers seem to recognize that dissemination
of their findings to nonresearch audiences is a main reason
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for their research and rate it as important; however, the main
method they use to reach this audience is through traditional
academic venues.Overall,most of the variables exploredwere
associated with self-rated dissemination effort in the pooled
sample. However many of these factors had low prevalence in
the countries explored. It seems there are limited support and
resources to make it easier for researchers whomight want to
disseminate their findings. The study also revealed that less
than one-third of researchers felt the level of effort they put
toward dissemination efforts was excellent. This may in part
explain the speed at which research is being translated into
practice [7, 33]; many researchers may lack access or may be
unaware of the effective methods of knowledge translation.
Our modeling indicated factors related to increased
success in dissemination by researchers, and these included
access to the right resources and practicing designing for
dissemination activities. Researchers reporting a unit/depart-
ment/school with a formal communication dissemination
strategy had higher odds of better self-rated effort. Unfor-
tunately, even though access was somewhat higher in the
US, it was low across the three countries (with only about
one-third of participants in the pooled sample reporting
some access), indicating a lack of resources for dissemination
in developed and developing countries. Thus our findings
point to the potential for provision of such resources to
enhance the ability of researchers to improve their efforts
to disseminate. Alternately, formation of a transdisciplinary
team may be a more feasible approach. It may not be feasible
or even advisable for a public health researcher to develop
all of the necessary dissemination skills. Teaming with a
communications ormarketing expertmight allow for optimal
dissemination. Whether the dissemination efforts are by the
researchers themselves, team members with dissemination
expertise, or outside experts, they will likely involve some
type of technology [34–36]. Many of the methods of dis-
semination mentioned by researchers in the current study
are conducted at least in part online. In particular, the
growth of online publishing and potential of social media
now offers a multitude of low cost, high reach channels
for the dissemination of information about prevention and
treatment of cardiovascular disease. Future efforts should
explore how tomaximize themultitude of technological plat-
forms and utilize target audience preferences for effective
dissemination [37].
Better connections between researchers and practice are
another avenuewhich has been suggested as a way to improve
translation of research to practice [38, 39]. This may be
particularly true in low and middle income countries [40].
This analysis found significant associations between whether
the researcher had practice-based experience and self-rated
dissemination effort in two of the countries explored (data
not shown) [25]. Training programs offering researchers
practice-based experience and also valuing practice experi-
ence in faculty recruitment and promotion requirementsmay
serve as a way to build these connections. For example, the
American Heart Association conducts a course: Seminar on
the Epidemiology and Prevention of Cardiovascular Disease
that brings together researchers and practitioners working
on cardiovascular health promotion [41]. Such programs
could be expanded to include management and treatment of
cardiovascular disease, furthering the impact of research into
practice.
Designing for dissemination is an active process that
helps to ensure that public health interventions, often eval-
uated by researchers, are developed in ways that match well
with adopters’ needs, assets, and time frames [25]. Additional
training in designing for disseminationmay be needed across
countries for researchers developing cardiovascular disease
prevention and treatment interventions [42]. Structural fac-
tors in the architecture of research institutions may also be
important barriers to engage in designing for dissemination
[43]. There was a difference in both the importance of
dissemination and the use of designing for dissemination
practices among Brazilian researchers; further, the US lagged
the other countries. Though it was not universal across
activities, Brazilian researchesmost frequently reported plan-
ning dissemination-related activities early, always or usually
evaluating the impact of their research on changing public
health practice or policy, and spending greater than 20% of
their time on dissemination-related activities. These factors
may be related to the fact that researchers embracing the
importance of dissemination may also be the researchers
who are more likely to engage in designing for dissemi-
nation activities, such as involving stakeholders earlier in
the research process. Some cardiovascular disease prevention
programs, which were designed with dissemination in mind,
have been scaled up, allowing them to have broad, population
health impacts [9]. For example, the Child and Adolescent
Trial forCardiovascularHealth (CATCH), an evidence-based
program for youth in United States schools, has engaged
diverse stakeholders and has been widely disseminated and
adopted [44–46]. In Brazil, Guide for Useful Interventions
for Activity in Brazil and Latin America (GUIA), a cross-
national academic-government partnership, used evidence of
effectiveness to trigger political action to scale up Academia
da Sau´de (a community-based physical activity intervention)
at the national level [47].
While the top reasons to disseminate were similar across
countries, there were apparent differences observed, which
indicate that messaging to enhance researcher dissemination
may need to be different across countries, as the reasons
behind such efforts differ. This may reflect local culture,
political environment, and/or other factors. For example,
in the UK applied health research has a strong emphasis
(from the major funding source National Institute for Health
Research) on producing research to address National Health
Service priorities and to support decision making by health
professionals and policy makers, which may have led to
more frequent reporting of influencing policy and attracting
future funding among this population. However, relative to
the top reasons for dissemination, these were reported less
frequently. The role of funders may therefore be important
not only because many dissemination activities are often
unfunded [48] but also because funders can set the priority
of the project to include dissemination [49–51]. Funders
of research in the prevention, management, and treatment
of cardiovascular disease may consider making this an
important priority in the development of calls for proposals
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and review criteria. Repeating this survey in other countries
might identify additional points for country-specific actions.
There are additional benefits to repeating the survey in these
three countries and replicating this project in other countries
so they might identify areas for improvement. This might
allow countries to see how they can improve dissemination
to nonresearch audiences, as many countries are spending
large amounts of money on research. Further, a coordinated
approach to administration of surveys similar to the ones
used in the current work in a large number of countries, with
a variety of education and funding structures, would allow for
additional pooled analyses. This might shed light on whether
there are systematic differences in the reasons researchers
disseminate their findings as well as what structures might
be most supportive.
This study had limitations worth noting. First, each coun-
try conducted the study in a different context; thus common
demographicmeasures are not available across countries, and
there was variation in time of delivery. Considering the speed
at which the field of dissemination research is moving, it
is possible that substantive changes may have occurred in
the use of research dissemination practices. The differences
in demographics collected across countries prevent presen-
tation of field of research and publication records for the
survey respondents. However, this study did not aim to look
at individual-level predictors of dissemination. Further, ques-
tions may have been interpreted differently across countries,
perhaps leading to some of the cross-country differences
observed. Additionally, the researchers in the study were
not a systematic nationwide sample, but they were meant
to represent sectors of research. The administration of the
survey in only three countries limits the generalizability of
the findings, though the countries included were diverse
in context. As this data was collected by self-report, there
is always the potential for social desirability bias. Further,
information on who did and did not participate is not
available, leaving open the potential for bias, as the sample
likely includes those most interested. Finally, the cross-
sectional nature of the study limits our ability to determine
causality. Despite these limitations, this study provides a first
of its kind look at dissemination and dissemination-related
factors among researchers in health-related fields across three
countries.
5. Conclusions
This study identified that researchers are interested in dis-
seminating the results of their research to raise awareness
and to influence practice and/or policy. Though intentions
seem to show the importance of dissemination, researchers
across countries appear to lack supports to enhance their
dissemination efforts. Additional resources as well as training
in designing for dissemination along with improved partner-
ships could help bridge the research-practice gap.
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